Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Sara Dong

Transplant/Immunocompromised States · Boston Children's Hospital

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Keith Kaye

General ID · RU

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Kelly Dooley

Mycobacterial Disease · Vanderbilt

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract Infections.

    Aug 6, 2025DOI: 10.1093/cid/ciaf293Journal ArticleCID

    Written by: Daniel J MinterTsai-Wei WangAbigail RaderKaren D BartonLesley A SkallaHelen W BoucherDeborah CollyarJulie MillerKatherine N SuttonMegan OakesFelicia RuffinHeather A KingSarah B Doernberg

    Find these authors on Roon

    HB
    Dr. Helen Boucher
    Transplant/Immunocompromised States · Tufts

    Summary

    BACKGROUND: Complicated urinary tract infections (cUTIs) significantly affect patients' health-related quality of life (HRQoL), yet current end points defined by the United States Food and Drug Administration for antibiotic registrational trials fail to capture important elements of the patient experience with cUTI. In this systematic review, we aimed to identify measurement tools for HRQoL that have been studied in patients with cUTIs.METHODS: Following a prospectively registered protocol in PROSPERO (CRD42020215641), English-language articles were queried using MEDLINE (via PubMed), Embase (Elsevier), and CINAHL (EBSCO) from database inception to 12 October 2022.RESULTS: We identified 24 articles (96% rated as high quality) with 22 distinct measures. Overall, 45% of measures were categorized as generic and 27% as condition-specific; 27% were developed by researchers. Qualitative studies provided details regarding patient experience across multiple HRQoL domains.CONCLUSIONS: Our results add to the limited literature on HRQoL measures studied in cUTI and emphasize the importance of standardization, development, and validation of instruments to incorporate patients' voices into novel trial end points for cUTI.
    HBDr. Helen Boucher
    Leading Voice

    Dr. Helen Boucher

    Infectious Disease · Transplant/Immunocompromised States
    Tufts University
    helen